Re: [ccp4bb] Kd's in Crystals

2011-06-28 Thread George Kontopidis
Determination of Kd in crystal using only crystallographic data 
look at 

The First Direct Determination of a Ligand Binding Constant in Protein
Crystals
Wu SY, Dornan J., Kontopidis G., Taylor P.,  Walkinshaw M.D.
Angew Chem Int Ed Engl, 2001, 40, 582-586.




George 

--- 
George Kontopidis 
Associate Professor of Biochemistry 
Head of Biochemistry 
Veterinary School, University of Thessaly 
Trikalon 224, Karditsa 43100, Greece 
Tel: +30 24410 66017 
Mob: 69 342 643 75 
Fax: +30 24410 66041 
e-mail: gkontopi...@vet.uth.gr 
web site: http://www.vet.uth.gr/english/departments_biochemistry.html 
--- 



-Original Message-
From: CCP4 bulletin board [mailto:CCP4BB@JISCMAIL.AC.UK] On Behalf Of Steven
Herron
Sent: Monday, June 27, 2011 9:33 PM
To: CCP4BB@JISCMAIL.AC.UK
Subject: Re: [ccp4bb] Kd's in Crystals

I had success using crystallography to measure the Ca2+ affinity (in the mM
range) for a Ca2+ dependent enzyme.  
 
See:
Characterization and implications of Ca2+ binding to pectate lyase C.
Herron SR, Scavetta RD, Garrett M, Legner M, Jurnak F.
J Biol Chem. 2003 Apr 4;278(14):12271-7.
 
We measured the occupancy of the Ca2+ ion using three different pH's and
3-4 different Ca2+ concentrations.  The presence of the Ca2+ ion altered the
conformation of two residues in the binding pocket.  In several of the
Ca2+ soak experiment the occupancy was between 35% and 70%, where both
orientations of the side chains could be modeled separately and their
occupancy values refined (see attached picture).  We confirmed our
crystallographic Kd approach using tryptophan fluorescence.  Since it was
difficult to measure mM binding affinities using dialysis or titration
calorimetry, we turned to crystallography (since we had lots of crystals
and beam time).   

Steve







Jacob Keller wrote:

Dear Crystallographers,

what is the dogma with regard to affinities in crystals? For example, 
if I soak three crystals in 1pM, 1nM, and 1uM compound X, and they all 
show equivalent density, does that mean that the affinity is really 
better than 1pM, or is the crystal of such a high local concentration
(~600mg/mL) that it will be fully occupied at nearly any concentration, 
provided external ligand concentration does not change due to binding 
in the crystal? I guess there is also the problem that the 
crystallization solutions are very non-physiological, but neglecting 
that, is there any straightforward way to think of this, or is there a 
good reference?

Jacob Keller

  



[ccp4bb] changing residue numbering in Coot

2011-06-28 Thread Katrina L Molland
Hello,
I am trying to use Coot to change the numbering of the residues in a PDB file. 
The structure contains six semi-identical lettered chains, currently described 
as D through I. For some reason, the feature in coot that should allow me to 
change them to A-F, as well as change the residue numbering, will only allow me 
to alter the first chain. Any ideas? The only other solution I can think of is 
to directly alter the text of the PDB file, but the tedious nature of the task 
and the possibility of introducing mistakes makes it rather unattractive.
Thanks in advance,
Katie Molland
Purdue University, Department of Biology


Re: [ccp4bb] changing residue numbering in Coot

2011-06-28 Thread Paul Emsley

On 28/06/11 12:13, Katrina L Molland wrote:

I am trying to use Coot to change the numbering of the residues in a PDB file. 
The structure contains six semi-identical lettered chains, currently described 
as D through I. For some reason, the feature in coot that should allow me to 
change them to A-F, as well as change the residue numbering, will only allow me 
to alter the first chain. Any ideas? The only other solution I can think of is 
to directly alter the text of the PDB file, but the tedious nature of the task 
and the possibility of introducing mistakes makes it rather unattractive.


So, IIUC, you can change D - A, but E - B fails.  E - B should fail 
if there is a B chain already - even if it has only one atom in it.


If there is no B chain, then E - B should work.  If it does not work 
you may well have discovered a bug.  What does the console say?


You might like to try the following (Calculate - Scripting - Scheme):

(change-chain-id 0 B E 1 1 999)

Where the 0 is the molecule number of the model you are trying to modify 
- you might need to change that
and 999 is the last residue number in the chain - you might need to 
modify that too.


Paul.


Re: [ccp4bb] Sc calculation

2011-06-28 Thread Mike Lawrence
Hi Fahimeh,

what has happened here is that the interface area in the new file is very
small, particularly after the periphery is trimmed (see the original
paper for how this is defined). For the old file, the area is about 1100
Angs**2, for the new it is about 110 Angs**2. As the log file states, Sc
is then not a very good measure of complementarity.

sincerely

Mike Lawrence

 Hello :)

 I am trying to find the shape complementarity of two structures. both of
 them are two layer of betasheet, that I have excluded hydrogens. in one of
 them (old.pdb, attached to the email) I have two complete layer in which
 chain A are all the strands in one layer and chain B are all the strands
 in
 the other layer. and in the other structure (new.pdb) I removed two
 strands
 from the middle of betasheet.
 I run Sc and the results are attached in sc_old.log and sc_new.log

 As you can see, sc factor is higher in the second structure , which is
 missing two strands in the middle?!
 How it is possible? I am confused ;)
 Am I missing something?

 Thank you in advance
 Fahimeh




__
The information in this email is confidential and intended solely for the 
addressee.
You must not disclose, forward, print or use it without the permission of the 
sender.
__


[ccp4bb] AW: [ccp4bb] changing residue numbering in Coot

2011-06-28 Thread Stefan Gerhardt
Hi,

worth to try moleman
- %moleman
Choose READ_pdb_file
- your_pdbfile.pdb
Choose AUTO_chain_segid
Choose WRITE_pdb_file
- out.pdb

Or the tedious NEDIT way 
Open your pdb.file in nedit, mark ONLY the chain ID column - put your cursor 
before the first X, press  [Shift][Ctrl], go the the last X in your chain. 
Then perform a replace/Find by selecting only the Selection option ... 
done. Repeat for each chain.

Cheers
Stefan
__
Dr Stefan Gerhardt
Albert-Ludwigs-Universität Freiburg
Inst. f. Org.Chemie u. Biochemie
Raum 911
Albertstrasse 21
79104 Freiburg

office: +49 761 2035970


Re: [ccp4bb] changing residue numbering in Coot

2011-06-28 Thread Tim Gruene
Dear Katie,

the menu entry Calculate - Change Chain ID works fine, although in the
current version (0.6.1), you cannot use the preselected Whole Chain radio
button but have to explicitly tell coot the residue range 'from' - 'to'.

Tim

On Tue, Jun 28, 2011 at 07:13:56AM -0400, Katrina L Molland wrote:
 Hello,
 I am trying to use Coot to change the numbering of the residues in a PDB 
 file. The structure contains six semi-identical lettered chains, currently 
 described as D through I. For some reason, the feature in coot that should 
 allow me to change them to A-F, as well as change the residue numbering, will 
 only allow me to alter the first chain. Any ideas? The only other solution I 
 can think of is to directly alter the text of the PDB file, but the tedious 
 nature of the task and the possibility of introducing mistakes makes it 
 rather unattractive.
 Thanks in advance,
 Katie Molland
 Purdue University, Department of Biology
 

-- 
--
Tim Gruene
Institut fuer anorganische Chemie
Tammannstr. 4
D-37077 Goettingen

GPG Key ID = A46BEE1A



pgpjDpB2BtbhE.pgp
Description: PGP signature


[ccp4bb] Protein scientist position at Syngenta

2011-06-28 Thread Daniel Kloer
Protein Scientist
£28,000 - £35,000 + benefits
Jealott’s Hill, Bracknell, Berkshire

As an independent worker, you will be a part of our Protein Production
Team, providing protein expression/purification support in a timely
manner across a range of Crop Protection Research projects. This will
involve carrying out small to medium-scale protein purification and
delivering purified proteins for assays and crystallography and
communicating results to the project team to influence/guide project
decisions. You will also have the opportunity to conduct expression
screening in E.coli (essential), insects and yeast (desirable), as
well as purifying and characterising difficult to express proteins in
heterologous systems with genes from a variety of sources.

With a BSc/PhD in protein biochemistry and or relevant lab experience
you will have the skills in isolating proteins from complex mixtures,
both native and recombinant sources. Experience in working with
membrane protein and kinases would be highly advantageous.
Bioinformatics skills to analyse DNA and protein data and the ability
to deal with academic and industrial collaborators, including CROs,
are also desirable. You should also have the ability to learn quickly
and apply new skills with excellent organisational skills.

To apply online, please visit www.syngenta.com and navigate to our
current vacancies via the career page.
Closing date: 1st July 2011.

Syngenta is one of the world's leading companies with more than 26,000
employees in over 90 countries dedicated to our purpose: Bringing
plant potential to life. Through world-class science, global reach and
commitment to our customers we help to increase crop productivity,
protect the environment and improve health and quality of life. For
more information about us please go to www.syngenta.com


[ccp4bb] PhD student position

2011-06-28 Thread Petri Kursula
Dear colleagues,
I would appreciate it if you could bring this off-topic opportunity to the 
attention of any suitable candidates.
Petri

---
A PhD student position is available in the group of Dr. Petri Kursula, to use 
neutron scattering methods to study proteins specifically expressed in the 
vertebrate myelin sheath. These proteins have functions e.g. in the 
interactions between the myelin sheath and the axon, and in the compaction of 
the multilayered myelin membrane.  

The project will involve large-scale recombinant expression of myelin proteins 
and studying their structure and function using mainly neutron scattering. The 
student will focus on the structure and dynamics of myelin proteins and their 
complexes, as well as their interactions with membranes. Complementary 
experiments will be carried out using X-rays and other biochemical/biophysical 
methods.

The ideal candidate will:
- have an MSc degree in biochemistry, physics, or a related field
- have experience in recombinant protein expression and purification and/or in 
X-ray and neutron scattering methods 
- be genuinely interested in using neutrons to study biological macromolecules
- be fluent in English

The selected candidate will be affiliated with the Department of Biochemistry, 
University of Oulu, Finland, but a large part of the work is expected to be 
carried out at the Centre for Structural Systems Biology (CSSB-HZI), on-site 
the DESY synchrotron campus, Hamburg, Germany. The work will also involve 
performing measurements at international neutron infrastructures, and will be 
carried out in collaboration with staff at such facilities, including the ILL 
(Grenoble). The position will be funded by the European Spallation Source 
(ESS). 

More information about our group can be found at www.biochem.oulu.fi/kursula, 
and informal queries by email are also welcome.

To apply, please send your cv, including list of publications, plus the names 
and email addresses of 2-3 referees by email to petri.kurs...@oulu.fi. The 
application deadline is July 31st, 2011.

---
Petri Kursula, PhD
Group Leader and Docent of Neurobiochemistry (University of Oulu, Finland)
Visiting Scientist (CSSB-HZI, DESY, Hamburg, Germany)
www.biochem.oulu.fi/kursula
www.desy.de/~petri
petri.kurs...@oulu.fi
petri.kurs...@desy.de
---



[ccp4bb] Postdoctoral position available

2011-06-28 Thread Brian Mark
POSTDOCTORAL POSITION AVAILABLE

Applications are invited for a postdoctoral position to investigate the 
structural and cellular biology of viral immune evasion tactics and assembly 
mechanisms of Bunyaviruses, the largest family of negative-strand RNA viruses.  
The family Bunyaviridae includes a number of emerging viruses of human and 
agricultural importance and much remains to be discovered about their life 
cycle and the mechanisms they use to subvert the innate immune system.  
The following is an example of our recent work in this area:  James TW, et al. 
(2011). Proc Natl Acad Sci U S A. 108(6):-7.

A number of exciting projects are underway and ready to carry forward.  More 
information about our lab can be found at: 
http://home.cc.umanitoba.ca/~bmark/Welcome.html
 
We seek enthusiastic applicants who hold a PhD in biochemistry or related 
field. Candidates must have a strong background in molecular biology and 
protein X-ray crystallography. Expertise in mammalian cell culture and 
fluorescence microscopy would be considered strong assets.
 
Our group is located in the Department of Microbiology, University of Manitoba, 
Winnipeg, Canada. The laboratory includes state-of-the-art X-ray 
instrumentation (Rigaku) and crystallization robotics (Art Robbins).  We have 
routine access to the Canadian Light Source Synchrotron via mail-in service, 
remote control of robotics, or in person (within driving distance).
 
The University of Manitoba (http://umanitoba.ca/) is the largest University in 
the province (over 30,000 students, faculty, and staff) and hosts a dynamic 
biomedical research community.  Winnipeg is a vibrant, multicultural city with 
numerous cultural events, festivals and a brand new NHL hockey team 
(http://www.destinationwinnipeg.ca/).  With over 110,000 fresh water lakes in 
our province alone, there is also much to explore for those who love the 
outdoors.
 
Salary will be in accordance with the Canadian Institutes of Health Research 
(CIHR) (http://www.cihr.ca/ ) standards.  Fellowship funding is also available 
through agencies such as the CIHR and the Manitoba Health Research Council 
(MHRC) (http://www.mhrc.mb.ca/).
 
All qualified candidates are encouraged to apply.
 
Please direct formal and informal inquiries and CV's (including names of three 
referees) to my email address:
 
brian_m...@umanitoba.ca


=
Brian Mark, MSc, PhD
Associate Professor
Manitoba Research Chair in Structural Biology
Department of Microbiology
 Department of Biochemistry and Medical Genetics

Mailing/Courier address:
Department of Microbiology
418 Buller Building
University of Manitoba
Winnipeg, Manitoba 
CANADA R3T 2N2

Phone (204) 480-1430
Fax (204) 474-7603
Web:  http://home.cc.umanitoba.ca/~bmark/Welcome.html








[ccp4bb] selenomethionine contact

2011-06-28 Thread Alexander U. Singer
Hi -- I have a case in which I have a refined structure in which the  
'so-far' measured distance between the Se atom of a selenomethionine  
and its crystallographic neighbouring Se atom (same residue) is 2.9 A,  
and I see continuous density between the two atoms.  Has anyone  
subscribing to this newsgroup come across a case in which methionine S  
atoms and/or selenomethionine Se atoms form disulfide/diselenide bonds  
in the crystal, and what does that mean in terms of its possible  
presence biologically?


Thanks for your help

Alex

--
Dr. Alex Singer
C.H. Best Institute
112 College St. Room 70
University of Toronto
Toronto, Canada, M5G 1L6
416-978-4033


Re: [ccp4bb] selenomethionine contact

2011-06-28 Thread Jacob Keller
Sounds to me like an artifact of the two-fold (I think there must be
one between the two atoms if it is the same residue?). I think things
get dicey near the symmetry axes...

JPK

On Tue, Jun 28, 2011 at 6:25 PM, Alexander U. Singer
alexander.sin...@utoronto.ca wrote:
 Hi -- I have a case in which I have a refined structure in which the
 'so-far' measured distance between the Se atom of a selenomethionine and its
 crystallographic neighbouring Se atom (same residue) is 2.9 A, and I see
 continuous density between the two atoms.  Has anyone subscribing to this
 newsgroup come across a case in which methionine S atoms and/or
 selenomethionine Se atoms form disulfide/diselenide bonds in the crystal,
 and what does that mean in terms of its possible presence biologically?

 Thanks for your help

 Alex

 --
 Dr. Alex Singer
 C.H. Best Institute
 112 College St. Room 70
 University of Toronto
 Toronto, Canada, M5G 1L6
 416-978-4033




-- 
***
Jacob Pearson Keller
Northwestern University
Medical Scientist Training Program
cel: 773.608.9185
email: j-kell...@northwestern.edu
***